Plasma levels of trefoil factors are increased in patients with advanced prostate cancer

E.M. Vestergaard, Michael Krabbe Borregaard, Steen Seier Poulsen, E. Nexo, N. Torring

59 Citationer (Scopus)

Abstract

Through cDNA array analyses and immunohistochemistry on tissue microarrays, trefoil factor 3 (TFF3) was recently shown to be overexpressed in prostate cancer. The purpose of this study was to test the feasibility of using the levels of trefoil factors as a plasma marker for prostate cancer.
OriginalsprogEngelsk
TidsskriftClinical Cancer Research
Vol/bind12
Udgave nummer3 Pt 1
Sider (fra-til)807-812
Antal sider6
ISSN1078-0432
DOI
StatusUdgivet - 2006

Fingeraftryk

Dyk ned i forskningsemnerne om 'Plasma levels of trefoil factors are increased in patients with advanced prostate cancer'. Sammen danner de et unikt fingeraftryk.

Citationsformater